# A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer

> **NCT02293707** · PHASE2 · COMPLETED · sponsor: **Laboratoires Leurquin Mediolanum** · enrollment: 99 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** GX301

## Key facts

- **NCT ID:** NCT02293707
- **Lead sponsor:** Laboratoires Leurquin Mediolanum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-08
- **Final completion:** 2019-11
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2020-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293707, "A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02293707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*